Startseite
Fermion Oy logo
Fermion Oy

Fermion Oy

1.3K
33
24
3.9(57)

Über das Unternehmen

  • Firmenname (rechtlich): Fermion Oy
  • Registrierungsland: Finland
  • Adresse: Koivu-Mankkaan tie 6 A, FI-02200 Espoo
  • Anzahl der Mitarbeiter: 250 - 499
Beschreibung:

Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

Geschäftsaktivitäten

Vertrags- & Outsourcing-Dienstleistungen

HerstellerDienstleisterLohnhersteller (CMO)API-Hersteller

Original-Wirkstoffe

HerstellerLohnhersteller (CMO)API-Hersteller

Zulassungs- & Marktanalyse-Dienstleistungen

Dienstleister

Labor- & Analysedienstleistungen

Dienstleister

Unsere Produkte & Dienstleistungen

Sell · Active Pharmaceutical Ingredients (APIs)
Nintedanib Esylate - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Alprazolam - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Mercaptopurine - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Budesonide - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Formoterol Fumarate - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Methotrexate - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Carbidopa - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Nadolol - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Entacapone - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Toremifene Citrate - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Levosimendan - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Dabrafenib Mesylate - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Tolnaftate - Fermion Oy

Certifications

CEP-Zertifikat

FDA

DMF

GMP

Proofs

CPHI Americas 2026
CPHI Americas 2026
06/2026 – 06/2026

CPHI Americas 2026

Standort
Pennsylvania Convention Center, Philadelphia
Filter:
Sortieren nach:

    Keine Kommentare verfügbar.